Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

A brand-new Porsche 911 Carrera S worth PHP 18 million took center stage on January 20, 2025, as Landers Superstore awarded ...

A brand-new Porsche 911 Carrera S worth P18 million took center stage on Jan. 20, 2025, as Landers Superstore awarded the ...

ByteDance’s OmniHuman-1 generates lifelike human videos from a single image and audio. Discover its key features and compare it with Sora and Veo 2.

Q4 2024 Earnings Call Transcript February 4, 2025 Alphabet Inc. beats earnings expectations. Reported EPS is $2.15, ...

A dazzling lineup of celebrities gathered at Landers Superstore’s 8th Anniversary Celebration on January 20, 2025, at its Arca South branch. From powerhouse performers to fan-favorite actors, the ...

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

For more information, download the full report. Vertex, Inc. is a leading global provider of indirect tax solutions. The Company’s mission is to deliver the most trusted tax technology enabling ...

Arbuckle, who is overseeing the drug’s launch, said Vertex has been planning for this approval for “a number of years.” The company has amassed 150 staff to sell Journavx, which it priced at $15.50 ...